Skip to main content
. 2024 Jun 8;14:13194. doi: 10.1038/s41598-024-64034-3

Table 4.

Association between CMI and hepatic fibrosis.

Modle1 Modle2 Modle3 Modle4
OR (95%CI) P OR (95%CI) P OR (95%CI) P OR (95%CI) P
CMI 1.37 (1.37 ~ 1.37) < 0.001 1.08 (1.08 ~ 1.08) < 0.001 1.05 (1.05 ~ 1.05) < 0.001 1.84 (1.84 ~ 1.85) < 0.001
CMI quartile
  Q1 (≤ 0.25) 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)
  Q2 (0.25 ~ 0.46) 2.23 (2.22 ~ 2.23) < 0.001 1.19 (1.19 ~ 1.20) < 0.001 1.08 (1.08 ~ 1.09) < 0.001 1.18 (1.18 ~ 1.19) < 0.001
  Q3 (0.46 ~ 0.81) 3.32 (3.31 ~ 3.33) < 0.001 1.27 (1.27 ~ 1.28) < 0.001 1.04 (1.04 ~ 1.05) < 0.001 1.22 (1.22 ~ 1.23) < 0.001
  Q4 (> 0.81) 6.10 (6.09 ~ 6.11) < 0.001 1.65 (1.64 ~ 1.65) < 0.001 1.28 (1.27 ~ 1.28) < 0.001 1.74 (1.74 ~ 1.75) < 0.001

Model 1 is unadjusted. Model 2 is adjusted for gender, age, race, and BMI. Model 3 is further adjusted for smoking, diabetes, and hypertension based on Model 2. Model 4 is additionally adjusted for TC, AST, GGT, ALB, BUN, TB, and UA based on Model 3.